09-09-2019 4 new articles have been published using with SHIKARI® ELISA Kits! For more information please go Publications page!
07-12-2019 3 new articles have been published using with SHIKARI® ELISA Kits! For more information please go Publications page!
“CandidaHunter: A Nanotechnology Based Blood Culture Medium to Detect Invasive Candida in Bloodstream” titled project has been granted by EU H2020 Phase-1. Matriks Biotek is aware that an innovation targeting the Candida, serves for both social and economic impacts of humanity.
CandidaHunter offers up to 80% detection sensitivity with a days earlier treatment opportunity. For more information and to get involved send us an email to email@example.com
06-17-2019 New article. SHIKARI® Q-NIVO ELISA Kit has been used to in study of "Therapeutic drug monitoring of nivolumab in clinical practice: Preliminary experience."
04-04-2019 New article. SHIKARI® Q-INFLIXI, Q-ATI, Q-ADA, S-ATA ELISA Kits have been used to in study of "Actual Anti-TNF Trough Levels Relate to Serum IL-10 in Drug-Responding Patients With Crohn’s Disease."
02-06-2019 New poster presentation. SHIKARI® Q-NIVO ELISA Kit has been used to in study of "ANÁLISIS DE LA CONCENTRACIONES PLASMÁTICAS DE NIVOLUMAB EN EL TRATAMIENTO DEL CPNM"
01-21-2019 New article. SHIKARI® Q-INFLIXI and SHIKARI® Q-ADA ELISA Kits have been used to in study of "Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn’s Disease." Digestive diseases and sciences (2018): 1-10.
12-19-2018 New article. SHIKARI® Q-INFLIXI ELISA Kit has been used to in study of "Infliximab Trough Levels Are Associated With Mucosal Healing During Maintenance Treatment With Infliximab in Paediatric Crohn’s Disease." Journal of Crohn's and Colitis (2018).
11-12-2018 New article. SHIKARI® Q-REMS ELISA Kit has been used to in study of "Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis–results from multicentre observational cohort." Expert opinion on biological therapy just-accepted (2018).
10-30-2018 New article. SHIKARI® Q-TRAS ELISA Kit has been used to in study of "Influence of anthropometric characteristics in patients with Her2-positive breast cancer on initial plasma concentrations of trastuzumab." Annals of Pharmacotherapy 51.11 (2017): 976-980.
10-11-2018 New SHIKARI® products! SHIKARI® Q-UST and SHIKARI® S-ATU ELISA kits for determination of Ustekinumab and anti-ustekinumab antibodies in serum/plasma.
10-10-2018 New article. SHIKARI® Q-INFLIXI ELISA kit has been used to in study of "Long-term Outcomes After Switching to CT-P13 in Pediatric-Onset Inflammatory Bowel Disease: A Single-Center Prospective Observational Study." Inflammatory bowel diseases (2018)
10-05-2018 New SHIKARI® products! SHIKARI® Q-VEDO and SHIKARI® S-ATV ELISA kits for determination of vedolizumab and anti-vedolizumab antibodies in serum/plasma.
10-01-2018 New article. SHIKARI® Q-ADA and SHIKARI® Q-INFLIXI ELISA kits have been used to in study of "Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation." Inflammatory bowel diseases (2018).
09-17-2018 We are looking for experienced and qualified distributor partners in the UK, France, Spain, Italy, Nordic Countries, USA, South American Countries, China, Australia and from all over the world. We welcome OEM solutions.